A phase II tolerability trial of neoadjuvant docetaxel with carboplatin and capecitabine in locally advanced breast cancer

Aruna Mani; Sandra X. Franco; Grace Wang; Neil Abramson; Lee S. Schwartzberg; James Jakub; Elizabeth Tan-Chiu; Michael A. Schwartz; Cynthia Frankel; Elisa A. Krill-Jackson; Alisha Stein; Alejandra T. Perez; Charles L. Vogel

doi:10.1016/S1548-5315(12)70012-8

A phase II tolerability trial of neoadjuvant docetaxel with carboplatin and capecitabine in locally advanced breast cancer

Aruna Mani, Sandra X. Franco, Grace Wang, Neil Abramson, Lee S. Schwartzberg, James Jakub, Elizabeth Tan-Chiu, Michael A. Schwartz, Cynthia Frankel, Elisa A. Krill-Jackson, Alisha Stein, Alejandra T. Perez, Charles L. Vogel

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Community oncology
Volume	8
DOIs	https://doi.org/10.1016/S1548-5315(12)70012-8
State	Published - May 1 2011

Disciplines

Medicine and Health Sciences
Oncology
Internal Medicine

Access to Document

10.1016/S1548-5315(12)70012-8License: Unspecified

Cite this

Mani, A., Franco, S. X., Wang, G., Abramson, N., Schwartzberg, L. S., Jakub, J., Tan-Chiu, E., Schwartz, M. A., Frankel, C., Krill-Jackson, E. A., Stein, A., Perez, A. T., & Vogel, C. L. (2011). A phase II tolerability trial of neoadjuvant docetaxel with carboplatin and capecitabine in locally advanced breast cancer. Community oncology, 8. https://doi.org/10.1016/S1548-5315(12)70012-8

@article{5adb3f47e29f4e41a5aae2b8f6d86c5e,

title = "A phase II tolerability trial of neoadjuvant docetaxel with carboplatin and capecitabine in locally advanced breast cancer",

author = "Aruna Mani and Franco, \{Sandra X.\} and Grace Wang and Neil Abramson and Schwartzberg, \{Lee S.\} and James Jakub and Elizabeth Tan-Chiu and Schwartz, \{Michael A.\} and Cynthia Frankel and Krill-Jackson, \{Elisa A.\} and Alisha Stein and Perez, \{Alejandra T.\} and Vogel, \{Charles L.\}",

note = "AB - This multicenter phase II trial evaluated the tolerability and efficacy of neoadjuvant chemotherapy in locally advanced breast cancer with four 28-day cycles of dose-dense chemotherapy: weekly docetaxel (30 mg/m2) and carboplatin (AUC 2) on days 1, 8, and 15, plus capecitabine (625 mg/m2) twice daily on days 5-18.",

year = "2011",

month = may,

day = "1",

doi = "10.1016/S1548-5315(12)70012-8",

language = "American English",

volume = "8",

journal = "Community oncology",

}

TY - JOUR

T1 - A phase II tolerability trial of neoadjuvant docetaxel with carboplatin and capecitabine in locally advanced breast cancer

AU - Mani, Aruna

AU - Franco, Sandra X.

AU - Wang, Grace

AU - Abramson, Neil

AU - Schwartzberg, Lee S.

AU - Jakub, James

AU - Tan-Chiu, Elizabeth

AU - Schwartz, Michael A.

AU - Frankel, Cynthia

AU - Krill-Jackson, Elisa A.

AU - Stein, Alisha

AU - Perez, Alejandra T.

AU - Vogel, Charles L.

N1 - AB - This multicenter phase II trial evaluated the tolerability and efficacy of neoadjuvant chemotherapy in locally advanced breast cancer with four 28-day cycles of dose-dense chemotherapy: weekly docetaxel (30 mg/m2) and carboplatin (AUC 2) on days 1, 8, and 15, plus capecitabine (625 mg/m2) twice daily on days 5-18.

PY - 2011/5/1

Y1 - 2011/5/1

UR - https://mayoclinic.pure.elsevier.com/en/publications/a-phase-ii-tolerability-trial-of-neoadjuvant-docetaxel-with-carbo

U2 - 10.1016/S1548-5315(12)70012-8

DO - 10.1016/S1548-5315(12)70012-8

M3 - Article

VL - 8

JO - Community oncology

JF - Community oncology

ER -

A phase II tolerability trial of neoadjuvant docetaxel with carboplatin and capecitabine in locally advanced breast cancer

Disciplines

Access to Document

Other files and links

Cite this